NCT00544934View on ClinicalTrials.gov

Multiple Dose Trial of Anti-glycation Agent GLY-230 in Healthy and Diabetic Subjects

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

42

Participants

Timeline

Start Date

February 28, 2007

Study Completion Date

October 31, 2007

Conditions

Diabetic Nephropathy

Interventions

DRUG

GLY-230

125, 250 0r 375 mg bid for 14 days

OTHER

Placebo

No drug administered

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Glycadia

INDUSTRY